Identification of 7,12-dimethylbenz[ a ]anthracene metabolites that lead to mutagenesis in mammalian cells
- 1 February 1979
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 76 (2), 862-866
- https://doi.org/10.1073/pnas.76.2.862
Abstract
The mutagenicity of 7,12-dimethylbenz[a]anthracene (DMBA) and 11 of its enzymatically derived metabolites was tested with Chinese hamster V79 cells for identification of mutagenic metabolites. The metabolites consisted of 7-hydroxymethyl-12-methylbenz[a]anthracene, 7-methyl-12-hydroxymethylbenz[a]anthracene, 7,12-dihydroxymethylbenz[a]anthracene, 3 trans-3,4-diols, 2 trans-5,6-diols and 3 trans-8,9-diols, all of which derived from DMBA or from the hydroxymethyl derivatives. Mutations were characterized by resistance to ouabain and 6-thioguanine. None of the tested metabolites were mutagenic in V79 cells, which do not metabolize polycyclic aromatic hydrocarbons. Mutagenesis in the V79 cells was tested with golden hamster cells capable of metabolizing polycyclic aromatic hydrocarbons (cell-mediated assay). In this assay, DMBA, 7-hydroxymethyl-12-methylbenz[a]anthracene, 7-methyl-12-hydroxymethylbenz[a]anthracene, and their trans-3,4-diols were mutagenic for both genetic markers, and the mutagenic response increased as a function of the hydrocarbon dose. All other metabolites were either inactive or showed up to a 4-fold higher mutation frequency than the untreated V79 cells for ouabain and 6-thioguanine resistance. The DMBA-trans-3,4-diol was the only metabolite that was more active than DMBA itself; at 0.05 .mu.M it was 6-8 times more active than DMBA in inducing both ouabain and 6-thioguanine resistance. This diol was mutagenic at a dose as low as 0.01 .mu.M. Mutagenesis by DMBA and the trans-3,4-diols was inhibited by 7,8-benzoflavone, an inhibitor of mixed-function oxidases. Analysis of DMBA metabolism in intact golden hamster cells indicated that DMBA-trans-3,4-diol is one of the major metabolites produced. DMBA-trans-3,4-diol may be metabolized to a diol-epoxide, presumably the trans-3,4-diol-1,2-epoxide, which may be a major reactive metabolite responsible for DMBA mutagenicity in mammalian cells.This publication has 54 references indexed in Scilit:
- DNA and RNA adducts formed in hamster embryo cell cultures exposed to benzo[a]pyreneBiochemistry, 1978
- Differences between products of binding of 7,12-dimethylbenz[a]anthracene to DNA in mouse skin and in a rat liver microsomal systemBiochemical and Biophysical Research Communications, 1978
- Evidence for the involvement of a diol-epoxide in the binding of 7,12-dimethylbenz(a)anthracene to DNA in cells in cultureChemico-Biological Interactions, 1977
- High mutagenicity of metabolically activated chrysene 1,2 dihydrodiol: Evidence for bay region activation of chryseneBiochemical and Biophysical Research Communications, 1977
- Metabolic activation of the carcinogen 7,12-dimethylbenz[a]anthracene for DNA bindingBiochemical and Biophysical Research Communications, 1977
- High microsome-mediated mutagenicity of the 3,4-dihydrodiol of 7-methylbenz[a]anthracene in S. typhimurium TA 98Biochemical and Biophysical Research Communications, 1977
- Mutagenesis and transformation of normal cells by chemical carcinogensNature, 1976
- Mutagenicity of metabolically activated benzo[a]anthracene 3,4-dihydrodiol: Evidence for bay region activation of carcinogenic polycyclic hydrocarbonsBiochemical and Biophysical Research Communications, 1976
- Mutagenicity of non-K-region diols and diol-epoxides of benz(a)anthracene and benzo(a)pyrene in S. typhimurium TA 100Biochemical and Biophysical Research Communications, 1975
- The effect of calf serum on the toxicity of 8-azaguanineMutation Research, 1975